Plus Therapeutics (PSTV) Raw Materials (2011 - 2019)
Plus Therapeutics (PSTV) reported Raw Materials of $663000.0 for Q1 2019, down 4.6% year-over-year from $695000.0 in Q1 2018, and down 12.53% quarter-over-quarter from $758000.0 in Q4 2018.
Plus Therapeutics (PSTV) Raw Materials (2011 - 2019) Analysis & Trends
Plus Therapeutics (PSTV) has 9 years of Raw Materials data on file, last reported at $663000.0 in Q1 2019.
- Raw Materials for Q1 2019 came in at $663000.0, down 4.6% year-over-year; the trailing twelve-month figure through Mar 2019 was $663000.0 (down 4.6% YoY), and the FY2018 annual result was $758000.0, up 11.31% from the prior year.
- Raw Materials retreated to $663000.0 in Q1 2019 per PSTV's latest filing, from $758000.0 in the prior quarter.
- Over five years, Raw Materials peaked at $1.7 million in Q1 2015 and troughed at $663000.0 in Q1 2019.
- A 5-year average of $1.0 million and a median of $907000.0 in 2017 frame the typical range for Raw Materials.
- The sharpest annual moves came in 2017 and 2018: Raw Materials jumped 56.58% in 2017, then sank 53.81% in 2018.
- A 5-year view of Raw Materials shows it stood at $1.0 million in 2015, then declined by 12.29% to $885000.0 in 2016, then retreated by 23.05% to $681000.0 in 2017, then increased by 11.31% to $758000.0 in 2018, then declined by 12.53% to $663000.0 in 2019.
- Business Quant data shows PSTV's Raw Materials at $663000.0 in Q1 2019, $758000.0 in Q4 2018, and $698000.0 in Q3 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - |
| 10 | Plus Therapeutics | 37.48 Mn | 22.37 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2019 | 663,000.00 |
| Dec 31, 2018 | 758,000.00 |
| Sep 30, 2018 | 698,000.00 |
| Jun 30, 2018 | 703,000.00 |
| Mar 31, 2018 | 695,000.00 |
| Dec 31, 2017 | 681,000.00 |
| Sep 30, 2017 | 907,000.00 |
| Jun 30, 2017 | 1.52 Mn |
| Mar 31, 2017 | 1.32 Mn |
| Dec 31, 2016 | 885,000.00 |
| Sep 30, 2016 | 831,000.00 |
| Jun 30, 2016 | 972,000.00 |
| Mar 31, 2016 | 981,000.00 |
| Dec 31, 2015 | 1.01 Mn |
| Sep 30, 2015 | 1.60 Mn |
| Jun 30, 2015 | 1.56 Mn |
| Mar 31, 2015 | 1.73 Mn |
| Dec 31, 2014 | 1.72 Mn |
| Sep 30, 2014 | 1.51 Mn |
| Jun 30, 2014 | 1.47 Mn |